Stockreport

Genelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business Updates

Genelux Corporation  (GNLX) 
PDF WESTLAKE VILLAGE, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financia [Read more]